☰

Roland Griffiths

Affiliations: 
School of Medicine Johns Hopkins University, Baltimore, MD 
Area:
Behavioral Pharmacology
Website:
http://www.bpru.org/bio/griffiths.html
Google:
"Roland Griffiths"
Mean distance: 15.22 (cluster 23)
 		SNBCP
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Travis Irving Thompson grad student

Children

Sign in to add trainee
John D.Roache grad student Johns Hopkins Medical School (PsychTree)
Lawrence P. Carter post-doc Johns Hopkins
Thomas S. Critchfield post-doc Johns Hopkins (PsychTree)
Matthew Johnson post-doc Johns Hopkins (PsychTree)
R J. Lamb post-doc Johns Hopkins
Katherine A. MacLean post-doc Johns Hopkins
Chad J. Reissig post-doc Johns Hopkins
Mary M Sweeney post-doc Johns Hopkins Medical School (PsychTree)
Frederick Streeter Barrett post-doc 2013- Johns Hopkins Medical School
Jack E. Henningfield post-doc 1978-1980 Johns Hopkins
Scott E. Lukas post-doc 1979-1982 Johns Hopkins
Stephen T. Higgins post-doc 1983-1985 Johns Hopkins
Warren K. Bickel post-doc 1984-1985 Johns Hopkins
Martin Iguchi post-doc 1986-1988 Johns Hopkins
Kenneth Silverman post-doc 1989-1991 Johns Hopkins
Elise Weerts post-doc 1993-1995
Thomas Eissenberg post-doc 1994-1996
Miriam Z. Mintzer post-doc 1995-1998 Johns Hopkins
Laura M. Juliano post-doc 2001-2002 American University (PsychTree)
Laura M. Juliano post-doc 2001-2002 American University (PsychTree)
Stacey C. Sigmon post-doc 2002-2004 Johns Hopkins (PsychTree)
Steven  E. Meredith post-doc 2012-2014 Johns Hopkins
Albert P. Garcia-Romeu post-doc 2012-2016 Johns Hopkins (PsychTree)
Albert P. Garcia-Romeu post-doc 2012-2016 Johns Hopkins (PsychTree)
Theresa Carbonaro post-doc 2013-2016
Manoj K. Doss post-doc 2018-2023 Johns Hopkins Medical School

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mathai DS, Hilbert S, Sepeda ND, et al. (2023) Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers. Psychedelic Medicine (New Rochelle, N.Y.). 1: 241-252
Doss MK, Samaha J, Barrett FS, et al. (2023) Unique effects of sedatives, dissociatives, psychedelics, stimulants, and cannabinoids on episodic memory: A review and reanalysis of acute drug effects on recollection, familiarity, and metamemory. Psychological Review
Nayak SM, Jackson H, Sepeda ND, et al. (2023) Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey. Frontiers in Psychiatry. 14: 1199642
Urrutia J, Anderson BT, Belouin SJ, et al. (2023) Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health. Journal of Psychoactive Drugs. 1-16
Gaddis A, Lidstone DE, Nebel MB, et al. (2023) Corrigendum to 'Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity': Neuroimage 2022 Oct 15;260:119434. Neuroimage. 274: 120130
Barrett FS, Zhou Y, Carbonaro TM, et al. (2022) Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation. Frontiers in Neuroergonomics. 2: 784576
Nikolaidis A, Lancelotta R, Gukasyan N, et al. (2022) Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms. Journal of Affective Disorders. 324: 239-249
Kiluk BD, Kleykamp BA, Comer SD, et al. (2022) Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review. Jama Psychiatry
Sweeney MM, Nayak S, Hurwitz ES, et al. (2022) Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying. Plos One. 17: e0271926
Henningfield JE, Coe MA, Griffiths RR, et al. (2022) Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling. Neuropharmacology. 109220
See more...